Zoth Lota S. bought ENGN
March 21, 2024 · Form 4 insider transaction
Zoth Lota S. bought 40,000 shares of enGene Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderZoth Lota S.
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 21, 2024
Filing dateMarch 25, 2024
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests at 1/3 on each of the first, second and third anniversaries of Ms. Zoth's date of appointment to the Board, which was December 18, 2023.